Skip to Content

McKesson Corp MCK

Morningstar Rating
$516.24 +5.94 (1.16%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

MCK is trading at a 26% premium.
Price
$516.24
Fair Value
$189.00
Uncertainty
Medium
1-Star Price
$611.90
5-Star Price
$452.00
Economic Moat
Zbdhmbs
Capital Allocation
Ljbdvbs

Bulls Say, Bears Say

Bulls

McKesson distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring McKesson’s profitability.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MCK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$510.30
Day Range
$509.37516.97
52-Week Range
$331.75519.75
Bid/Ask
$508.81 / $529.34
Market Cap
$67.84 Bil
Volume/Avg
687,248 / 855,449

Key Statistics

Price/Earnings (Normalized)
17.63
Price/Sales
0.23
Dividend Yield (Trailing)
0.45%
Dividend Yield (Forward)
0.48%
Total Yield
3.97%

Company Profile

McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Large Core
Total Number of Employees
51,000

Competitors

Valuation

Metric
MCK
CAH
COR
Price/Earnings (Normalized)
17.6315.1418.44
Price/Book Value
50.66
Price/Sales
0.230.120.17
Price/Cash Flow
14.4410.7914.47
Price/Earnings
MCK
CAH
COR

Financial Strength

Metric
MCK
CAH
COR
Quick Ratio
0.480.430.48
Current Ratio
0.920.980.88
Interest Coverage
14.7218.379.41
Quick Ratio
MCK
CAH
COR

Profitability

Metric
MCK
CAH
COR
Return on Assets (Normalized)
6.00%3.89%4.19%
Return on Equity (Normalized)
574.41%
Return on Invested Capital (Normalized)
66.76%89.85%48.08%
Return on Assets
MCK
CAH
COR
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Sponsor Center